Lifeboat Foundation

Whether people with rare genetic mutations that result in important medical discoveries should be compensated is a topic of intense debate.

“He is not here; He has risen,” — Matthew 28:6

As billions of Christians around the world are getting ready to celebrate the Easter festival and holiday, we take pause to appreciate the awe inspiring phenomena of resurrection.

In religious and mythological contexts, in both Western and Eastern societies, well known and less common names appear, such as Attis, Dionysus, Ganesha, Krishna, Lemminkainen, Odin, Osiris, Persephone, Quetzalcoatl, and Tammuz, all of whom were reborn again in the spark of the divine.

Continue reading “Resurrection and Biotechnology” »

Genetic mutations from extinct human relatives called the Denisovans might have influenced modern human immune systems, as well as fat and blood sugar levels, researchers say.

Very little is known about the Denisovans. The first evidence of them was discovered in Denisova Cave in Siberia in 2008, and DNA from their fossils suggests they shared an origin with Neanderthals but were nearly as genetically distinct from Neanderthals as Neanderthals were from modern humans.

Previous work found that any modern humans with ancestry outside of Africa inherited about 1.5 to 2.1 percent of their DNA from Neanderthals. In contrast, prior research suggested that substantial levels of Denisovan ancestry are found only in the Pacific islands of Melanesia. Scientists are increasingly uncovering the effects of Neanderthal ancestry on modern humans, from potential immune boosts to increased risks for depression, obesity, heart attacks, nicotine addiction. However, relatively little was known about the effects of Denisovan ancestry.

Continue reading “DNA from Mysterious ‘Denisovans’ Helped Modern Humans Survive” »

It sounds really obvious, but hospitals aren’t for healthy people. The world’s entire health system is really there to react once people get ill. If doctors are able to catch an illness at stage one that’s great, but if it reaches stage three or four there’s often not that much that can be done. So what if we could treat patients at stage zero and predict the likelihood of contracting diseases? We could then get treatment to people who need it much earlier and take preventative steps to avoid illness altogether.

Currently, when we think of monitoring in healthcare we’re usually referring to monitoring patients’ reactions to drugs or treatments, but this is changing. No amateur runner’s uniform is complete these days without a Fitbit or some kind of analytics tool to monitor progress, so the idea of monitoring the healthy is becoming ingrained in the public’s consciousness. But Fitbits only scrape the surface of what we can do. What if the data from fitness trackers could be combined with medical records, census data and the details of supermarket loyalty cards to predict the likelihood of contracting a particular disease?

With big data we can move from reacting to predicting, but how do we move beyond just making predictions; how do we prevent disease from occurring altogether? Up until now all of our monitoring technology has been located outside of the body, but nano-sized entities made of DNA could one day patrol the body, only acting when they come into contact with specific cells – cancer cells, for example. The technology that would turn tiny machines – roughly the size of a virus – into molecular delivery trucks that transport medication is already being worked on by bioengineers. If this kind of technology can be used to treat cancer, without needing to release toxic agents into the body, can the same technology be inserted into a healthy person and lie in wait for the opportunity to fight disease on its host’s behalf?

The body’s branching network of peripheral nerves connects neurons in the brain and spinal cord to organs, skin, and muscles, regulating a host of biological functions from digestion to sensation to locomotion. But the peripheral nervous system can do even more than that, which is why DARPA already has research programs underway to harness it for a number of functions—as a substitute for drugs to treat diseases and accelerate healing, for example, as well as to control advanced prosthetic limbs and restore tactile sensation to their users.

Now, pushing those limits further, DARPA aims to enlist the body’s peripheral nerves to achieve something that has long been considered the brain’s domain alone: facilitating learning. The effort will turn on its head the usual notion that the brain tells the peripheral nervous system what to do.

The new program, Targeted Neuroplasticity Training (TNT), seeks to advance the pace and effectiveness of a specific kind of learning—cognitive skills training—through the precise activation of peripheral nerves that can in turn promote and strengthen neuronal connections in the brain. TNT will pursue development of a platform technology to enhance learning of a wide range of cognitive skills, with a goal of reducing the cost and duration of the Defense Department’s extensive training regimen, while improving outcomes. If successful, TNT could accelerate learning and reduce the time needed to train foreign language specialists, intelligence analysts, cryptographers, and others.

On track to resolving defective RNA through CRISPR-Cas9.

According to a study published in journal Cell on March 17, researchers at University of California, San Diego School of Medicine, have found a way to track RNA in living cells. CRISPR-Cas9, a DNA-editing technique will be applied to target RNA in order to find cure for presently untreatable diseases such as cancer and autism.

There are many diseases that are associated with RNA behavior, which carries the genetic code from the cell’s nucleus. There was no technique found until now that could track RNA in living cells efficiently. However now, CRISPR-Cas9, which so far was only able to manipulate DNA, would now target RNA, which is also called RNA-targeted Cas9.

Continue reading “Research devises a way to track RNA in living cells through CRISPR-Cas9” »

It is a well known fact that many Glioblastoma patients are diagnosed through eye exams; many documented cases as well.

If it wasn’t for the appointment Judith Edwards, 65, might have lost her life.

Microscopic robots, powered by bacterial flagellation, are a curious branch of robotics research, potentially leading to devices that can deliver drugs, perform surgical tasks, and help out with diagnostics. While bacteria has been harnessed in the past to power small devices, having those devices actually navigate to a desired target has been a challenge. At Drexel University researchers are now using electric fields to help their bacterial biobots detect obstacles and float around them on their way to the final destination.

The electric fields don’t actually control the bots, but allow the bots to sense their environment and to move around. The devices are powered by rod-shaped S. marcescens bacteria that are normally negatively charged. The researchers positioned two electric fields orthogonally to each other, creating a grid. Obstacles within the grid slightly affect the fields’ shape, which the robot recognizes and uses to avoid the obstacles.

Here are a couple videos demonstrating the bacterial powered microbot:

Continue reading “Bacteria-powered Bio-Bots Avoid Obstacles on Way to Target” »

Now this is a cool concept; a studio that allows others to experiment and build their own Biocomputer, and other biotechnologies.

How does a leopard get its spots? A new exhibit at The Tech Museum of Innovation in San Jose has some clues about that.